Holdings of Trails Edge Capital Partners, LP
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 22 in 2 countries
- Top ten
- 70.3 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | VAXCYTE INC | 662,470 | 38.5M $ | |
| 2 | LB Pharmaceuticals Inc | 1,319,362 | 32.5M $ | |
| 3 | MIRUM PHARMACEUTICALS INC | 333,312 | 30.8M $ | |
| 4 | Nurix Therapeutics Inc | 1,743,220 | 27M $ | |
| 5 | REVOLUTION MEDICINES INC | 245,000 | 23.8M $ | |
| 6 | ARCUS BIOSCIENCES INC | 1,047,935 | 22.6M $ | |
| 7 | Immunocore Holdings PLC | 682,597 | 20.6M $ | |
| 8 | CYTOKINETICS INC | 300,000 | 19.8M $ | |
| 9 | Syndax Pharmaceuticals Inc | 701,821 | 16.4M $ | |
| 10 | Neurogene Inc | 782,787 | 15.8M $ | |
| 11 | INVENTIVA SA | 2,657,997 | 14.8M $ | |
| 12 | Inhibikase Therapeutics Inc | 8,057,345 | 13.5M $ | |
| 13 | 4D Molecular Therapeutics Inc | 1,302,917 | 12.1M $ | |
| 14 | X4 Pharmaceuticals Inc | 2,571,478 | 10.6M $ | |
| 15 | IMMUNOVANT INC | 414,054 | 10.3M $ | |
| 16 | Design Therapeutics Inc | 852,013 | 9.1M $ | |
| 17 | CAMP4 Therapeutics Corp | 1,939,563 | 8.6M $ | |
| 18 | Minerva Neurosciences Inc | 1,419,000 | 8.5M $ | |
| 19 | Century Therapeutics Inc | 2,449,993 | 5.5M $ | |
| 20 | vTv Therapeutics Inc | 139,578 | 5.5M $ | |
| 21 | SENSEI BIOTHERAPEUTICS INC | 125,000 | 3.9M $ | |
| 22 | Opus Genetics Inc | 500,000 | 2.3M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 95.8 %
- France 4.2 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 21 | 337.9M $ | 95.82 % |
| 2 | France | 1 | 14.8M $ | 4.18 % |
Cite this page
Titelia. "Holdings of Trails Edge Capital Partners, LP". https://titelia.com/en/funds/US13F2077247